Improved prevention of moderately emetogenic chemotherapy‐induced nausea and vomiting with palonosetron, a pharmacologically novel 5‐HT<sub>3</sub> receptor antagonist - Concepedia

Concepedia

Publication | Open Access

Improved prevention of moderately emetogenic chemotherapy‐induced nausea and vomiting with palonosetron, a pharmacologically novel 5‐HT<sub>3</sub> receptor antagonist

DOI Full Paper Access

404

Citations

7

References

2003

Year

Peter D. Eisenberg, Jazmin Figueroa‐Vadillo, Rosalio Zamora, Veena Charu, Julio Hajdenberg, Alan Cartmell, A. Macciocchi, Steven M. Grunberg

Abstract

A single dose of palonosetron is as effective as a single dose of dolasetron in preventing acute CINV and superior to dolasetron in preventing delayed CINV after moderately emetogenic chemotherapy, with a comparable safety profile for all treatment groups.

References

	Year	Citations

Page 1